Short-Interval, Low-Dose [177Lu]Lu–Prostate-Specific Membrane Antigen in the Treatment of Refractory Glioblastoma

From the Divisions of ∗Nuclear Medicine

†Radiation Oncology

‡Diagnostic Radiology, Department of Radiation Medicine, University of Cape Town, Cape Town, South Africa

§Department of Nuclear Medicine; Universität Ulm, Ulm, Germany.

Received for publication July 4, 2022; revision accepted January 14, 2023.

Conflicts of interest and sources of funding: none declared.

All authors contributed to the case report conception and design.

Correspondence to: Vikas Prasad, PhD, MBBS, Department of Nuclear Medicine, Universität Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany. E-mail: [email protected].

留言 (0)

沒有登入
gif